Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by lscfaon Mar 13, 2021 10:29am
181 Views
Post# 32792580

RE:RE:RE:RE:Let’s raise awareness

RE:RE:RE:RE:Let’s raise awarenessThere's plenty of firms for hire to write an investment research report on the co. Fundamental Research, eResearch and Zacks to name a few. Although the reports are paid for by the co. the analysis still needs to be based on facts and assumptions which readers can weight or discount. 


forhandlaren wrote: Not sure if I made myself clear previously. My point is that this company needs additional investors and therefore awareness activities are needed. Carried out by management and marketing firms as well as existing shareholders.

Regardless of news, it looks like we recycle the same shareholders over and over again. The news does not reach beyond ourselves!

R+F product launch has been announced. Multiple milestones just around the corner. Clinical results for skin lightener with higher concentration expected soon. Diversified company that differs from many other biotech with a single compound - Sirona has many including a pharmaceutical deal.

But here we are - stuck just above 40 cents... it's crazy - any normal comparable company would trade way above a buck!


<< Previous
Bullboard Posts
Next >>